Bayer issues EUR 1.3 billion in hybrid capital

more

Bayer launches jumbo bond issuance with a volume of USD 7 billion

Successful placement as part of the financing of the acquisition of the OTC business of Merck & Co., Inc., United States / Six tranches with maturities of two to ten years more

Not intended for U.S. Media - To finance the acquisition of the consumer care business of Merck & Co., Inc.

Bayer issues hybrid capital of EUR 3.25 billion

Largest corporate euro hybrid bond transaction worldwide more

Bayer issues EUR 2 billion of bonds

Transaction comprises two-year floating-rate tranche and two EUR 750 million fixed-rate bonds with maturities of four and seven years more

Bayer issues corporate bond with a volume of EUR 1.3 billion

more

To finance Bayer's investment program in Caojing, China:

Bayer successfully syndicates a EUR 610 million equivalent credit facility in China

Long-term credit facility available in Renminbi or U.S. dollars/ Syndication significantly oversubscribed more

Bayer bond issues successfully placed

more

Planned acquisition of Schering AG:

Bayer launches new bond issues to replace a further part of the bridge financing

Loan syndication successfully completed more

Overallotment option for Bayer Mandatory Convertible Bond fully exercised

more

Bayer – EUR 2 billion mandatory convertible bond successfully placed

Strong interest of capital market for subordinated mandatory convertible bond

more

Bayer announces the launch of a EUR 2 billion mandatory convertible bond

Subordinated mandatory convertible bond due in June 2009 / Conversion into shares of Bayer AG more

Enormous interest from investors

Bayer successfully completes refinancing

EUR 1.3 billion hybrid bond issued / Bayer repurchases bonds with a face value of around EUR 860 million more

Bayer repurchases part of Eurobond issue and launches new hybrid bonds

more

Bayer: Moody's downgrade incomprehensible

Debt reduction target exceeded, operating profit expected to grow more